Ardsley Advisory Partners LP Regenxbio Inc. Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$42.0 - $59.29 $252,000 - $355,740	-6,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $244,920 - $374,700	6,000 New	6,000 $344,000
Q2 2018 Aug 14, 2018	SELL	$27.2 - $74.35 $204,000 - $557,625	-7,500 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$24.05 - $37.5 $60,125 - $93,750	-2,500 Reduced 25.0%	7,500 $224,000
Q2 2017 Sep 21, 2017	BUY	N/A	10,000	10,000 $197,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.